{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:01:18Z","timestamp":1792522878423,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cellsig.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T06:51:17Z","timestamp":1491288677000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":429,"special_numbering":"C","title":["Niclosamide: Beyond an antihelminthic drug"],"prefix":"10.1016","volume":"41","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert A.","family":"Mook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Premont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2017.04.001_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, Bayluscide","volume":"19","author":"Andrews","year":"1983","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-102-4-550","article-title":"Niclosamide therapy for tapeworm infections","volume":"102","author":"Pearson","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0015","series-title":"The Selection and Use of Essential Medicines","author":"WHO","year":"2007"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/2211016a0","article-title":"Mechanism of action of reagents that uncouple oxidative phosphorylation","volume":"221","author":"Weinbach","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0025","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.158.3809.1694","article-title":"Salicylanilides: a new group of active uncouplers of oxidative phosphorylation","volume":"158","author":"Williamson","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0306-3623(96)00149-8","article-title":"The mechanisms of action of antiprotozoal and anthelmintic drugs in man","volume":"28","author":"Frayha","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4102\/jsava.v70i2.756","article-title":"The pharmacology of halogenated salicylanilides and their anthelmintic use in animals","volume":"70","author":"Swan","year":"1999","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J. Surg."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0045","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1158\/1078-0432.CCR-15-2256","article-title":"Identification of Niclosamide as a novel anticancer agent for adrenocortical carcinoma","volume":"22","author":"Satoh","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0050","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4103\/0973-1482.137927","article-title":"Breast cancer statistics and markers","volume":"10","author":"Donepudi","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029290","article-title":"Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/\u03b2-catenin pathway","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0060","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1535-7163.MCT-13-0555","article-title":"Effect of niclosamide on basal-like breast cancers","volume":"13","author":"Londono-Joshi","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0065","doi-asserted-by":"crossref","first-page":"17530","DOI":"10.1074\/jbc.M112.359638","article-title":"Structure-activity analysis of Niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of Rapamycin Complex 1 (mTORC1) signaling","volume":"287","author":"Fonseca","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0070","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2013.01.007","article-title":"Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells","volume":"25","author":"Kim","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0075","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ml100146z","article-title":"Identification of Niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway","volume":"1","author":"Ren","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0080","article-title":"Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0085","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.bmc.2015.07.026","article-title":"Addition of niclosamide to palladium (II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancer","volume":"23","author":"Karakas","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-1293-1","article-title":"Triple negative breast cancer: unmet medical needs","volume":"125","author":"Pal","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0095","doi-asserted-by":"crossref","first-page":"42126","DOI":"10.18632\/oncotarget.9704","article-title":"Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt\/\u03b2-catenin signaling","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0100","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1007\/s13277-015-4650-1","article-title":"Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0105","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/521S2a","article-title":"A disease of growth","volume":"521","author":"Holmes","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nrd2154","article-title":"Mining the Wnt pathway for cancer therapeutics","volume":"5","author":"Barker","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0115","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi9009677","article-title":"The anti-helminthic Niclosamide inhibits Wnt\/Frizzled1 signaling","volume":"48","author":"Chen","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0120","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-10-3978","article-title":"Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations","volume":"71","author":"Osada","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0125","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jnci\/djr190","article-title":"Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer","volume":"103","author":"Sack","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3892\/ijmm.2016.2689","article-title":"Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family","volume":"38","author":"Suliman","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.cellsig.2017.04.001_bb0135","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0140","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2741\/4362","article-title":"Glioma: an overview of current classifications, characteristics, molecular biology and target therapies","volume":"20","author":"Zeng","year":"2015","journal-title":"Front. Biosci."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0145","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/1078-0432.CCR-12-2895","article-title":"Anticancer effects of niclosamide in human glioblastoma","volume":"19","author":"Wieland","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0155","article-title":"Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0160","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1387\/ijdb.093049ab","article-title":"The Notch pathway in the developing hematopoietic system","volume":"54","author":"Bigas","year":"2010","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0165","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jcb.22065","article-title":"The autonomous Notch signal pathway is activated by Baicalin and Baicalein but is suppressed by Niclosamide in K562 cells","volume":"106","author":"Wang","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0170","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-16-0226","article-title":"Anthelmintic niclosamide disrupts the interplay of p65 and FOXM1\/beta-catenin and eradicates leukemia stem cells in chronic myelogenous leukemia","volume":"23","author":"Jin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0180","first-page":"1301","article-title":"Erlotinib in the treatment of non-small cell lung cancer: current status and future developments","volume":"30","author":"Gridelli","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0185","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/1535-7163.MCT-13-0095","article-title":"Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0190","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/1535-7163.MCT-13-0608","article-title":"Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer","volume":"13","author":"You","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0195","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.biopha.2014.03.018","article-title":"Niclosamide enhances ROS-mediated cell death through c-Jun activation","volume":"68","author":"Lee","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma","volume":"152","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0205","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/1568009615666150629132157","article-title":"The anthelmintic drug Niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways","volume":"15","author":"Liao","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0210","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1535-7163.MCT-12-0002","article-title":"Growth inhibition of ovarian tumor\u2013initiating cells by Niclosamide","volume":"11","author":"Yo","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0215","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/IGC.0000000000000506","article-title":"Niclosamide analogs for treatment of ovarian cancer","volume":"25","author":"Walters Haygood","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.04.005","article-title":"Inhibition of Wnt\/\u03b2-catenin pathway by niclosamide: a therapeutic target for ovarian cancer","volume":"134","author":"Arend","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0225","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/onc.2014.277","article-title":"WNT7A\/\u03b2-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer","volume":"34","author":"King","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0230","first-page":"365","article-title":"Mechanisms of resistance in castration-resistant prostate cancer (CRPC)","volume":"4","author":"Chandrasekar","year":"2015","journal-title":"Trans. Androl. Urol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0235","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0240","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cpt.256","article-title":"Androgen receptor targeting drugs in castration-resistant prostate cancer and mechanisms of resistance","volume":"98","author":"Crona","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0245","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-13-3296","article-title":"Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"20","author":"Liu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0250","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/pros.23015","article-title":"Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via STAT3-AR axis inhibition","volume":"75","author":"Liu","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2015.00090","article-title":"Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure","volume":"5","author":"Hu","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159675","article-title":"Extracellular pH modulates neuroendocrine prostate cancer cell metabolism and susceptibility to the mitochondrial inhibitor Niclosamide","volume":"11","author":"Ippolito","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.mou.0000135078.04721.f5","article-title":"Renal cell carcinoma: etiology, incidence and epidemiology","volume":"14","author":"Murai","year":"2004","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0270","article-title":"Bone Metastasis from Renal Cell Carcinoma","volume":"17","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0275","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1186\/s40064-016-3153-x","article-title":"Niclosamide suppresses renal cell carcinoma by inhibiting Wnt\/beta-catenin and inducing mitochondrial dysfunctions","volume":"5","author":"Zhao","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0280","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tube.2015.05.017","article-title":"Tuberculosis: a disease without boundaries","volume":"95","author":"Fogel","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1054\/tuld.1999.0212","article-title":"Antituberculosis activity of certain antifungal and antihelmintic drugs","volume":"79","author":"Sun","year":"1999","journal-title":"Tuber. Lung Dis."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0290","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/ml200157f","article-title":"Nitazoxanide disrupts membrane potential and intrabacterial pH homeostasis of Mycobacterium tuberculosis","volume":"2","author":"de Carvalho","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"61","key":"10.1016\/j.cellsig.2017.04.001_bb0295","first-page":"16","article-title":"Mycobacterium tuberculosis is selectively killed by Rifampin and Rifapentine in hypoxia at neutral pH","volume":"61","author":"Iacobino","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0300","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/AAC.02154-12","article-title":"Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions","volume":"57","author":"Piccaro","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.cellsig.2017.04.001_bb0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/toxins8030069","article-title":"The Ins and Outs of Anthrax Toxin","volume":"8","author":"Friebe","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0310","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1016\/j.bmc.2009.05.054","article-title":"Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro1818","article-title":"The biology and future prospects of antivirulence therapies","volume":"6","author":"Cegelski","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0320","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","author":"Benfield","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0335","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0340","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.48.7.2693-2696.2004","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide","volume":"48","author":"Wu","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0345","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1743-422X-7-264","article-title":"An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections","volume":"7","author":"Jurgeit","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0355","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/605496","article-title":"Chikungunya fever: an epidemiological review of a re-emerging infectious disease","volume":"49","author":"Staples","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0360","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2016.10.003","article-title":"Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission","volume":"135","author":"Wang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0365","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(16)00320-2","article-title":"Zika virus and microcephaly: why is this situation a PHEIC?","volume":"387","author":"Heymann","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0370","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0375","doi-asserted-by":"crossref","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0385","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.beem.2016.05.003","article-title":"Type 2 diabetes: a 21st century epidemic","volume":"30","author":"Jaacks","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/tvjl.1999.0377","article-title":"Fasciolicides: efficacy, actions, resistance and its management","volume":"158","author":"Fairweather","year":"1999","journal-title":"Vet. J."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0395","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm.3699","article-title":"Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice","volume":"20","author":"Tao","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0400","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cld.2015.10.014","article-title":"Nonalcoholic Fatty Liver Disease and Liver Transplantation","volume":"20","author":"Pham","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0405","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/micc.12293","article-title":"Mechanosensitive Gq\/11 protein-coupled receptors mediate myogenic vasoconstriction","volume":"23","author":"Mederos","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0410","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.phrs.2016.11.008","article-title":"Niclosamide ethanolamine inhibits artery constriction","volume":"115","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0415","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.fertnstert.2016.06.034","article-title":"Endocrine disrupting chemicals and endometriosis","volume":"106","author":"Smarr","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.116.140236","article-title":"Niclosamide as a potential nonsteroidal therapy for endometriosis that preserves reproductive function in an experimental mouse model","volume":"95","author":"Prather","year":"2016","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0425","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0430","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1007\/s11095-016-2027-9","article-title":"Niclosamide is a negative allosteric modulator of Group I Metabotropic Glutamate Receptors: implications for neuropathic pain","volume":"33","author":"Ai","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0435","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI65364","article-title":"WNT signaling underlies the pathogenesis of neuropathic pain in rodents","volume":"123","author":"Zhang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0440","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2174\/0929867323666160506125218","article-title":"Update on therapeutic spproaches for Rheumatoid Arthritis","volume":"23","author":"Nogueira","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0445","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00011-015-0801-5","article-title":"Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"64","author":"Liang","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0450","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.intimp.2015.11.002","article-title":"Niclosamide induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"31","author":"Huang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0455","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/leu.2016.367","article-title":"Novel targets in the treatment of chronic graft-versus-host disease","volume":"31","author":"Im","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0460","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jid.2016.06.624","article-title":"Improvement of Sclerodermatous Graft-Versus-Host Disease in mice by Niclosamide","volume":"136","author":"Morin","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0465","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of Systemic Sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0470","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.4049\/jimmunol.1502482","article-title":"Niclosamide prevents Systemic Sclerosis in a reactive oxygen species-induced mouse model","volume":"197","author":"Morin","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0475","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4161\/cc.22134","article-title":"Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch","volume":"11","author":"Bertrand","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0480","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1007\/s00018-014-1644-x","article-title":"Wnt-Notch signalling crosstalk in development and disease","volume":"71","author":"Collu","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046892","article-title":"The Wnt\/\u03b2-catenin pathway cross-talks with STAT3 signaling to regulate survival of retinal pigment epithelium cells","volume":"7","author":"Fragoso","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0490","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jth.13477","article-title":"Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR\/Wnt\/\u03b2-catenin signaling in endothelial cells","volume":"14","author":"Hassanian","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005400","article-title":"The role of the Hes1 crosstalk hub in Notch-Wnt interactions of the intestinal crypt","volume":"13","author":"Kay","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0500","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00535-007-2087-z","article-title":"Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision","volume":"42","author":"Nakamura","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0505","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.bmc.2017.01.046","article-title":"Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt\/\u03b2-catenin signaling with selectivity over effects on ATP homeostasis","volume":"25","author":"Mook","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0510","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1208\/aapsj070123","article-title":"Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic","volume":"7","author":"Yang","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0515","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, Bayluscide","volume":"19","author":"Andrews","year":"1983","journal-title":"Pharmac. Ther."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0520","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.exppara.2007.12.001","article-title":"In vitro trypanocidal activity of the anti-helminthic drug niclosamide","volume":"118","author":"Merschjohann","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0525","first-page":"329","article-title":"Pharmacokinetics of anti-SARS-CoV agent niclosamide and its analogs in rats","volume":"14","author":"Chang","year":"2006","journal-title":"Yaowu Shipin Fenxi"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0530","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3109\/03639045.2014.954585","article-title":"Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique","volume":"41","author":"Ye","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.cellsig.2017.04.001_bb0535","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.18632\/oncotarget.7113","article-title":"Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2017.04.001_bb0540","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1016\/j.bmc.2015.07.001","article-title":"Structure-activity studies of Wnt\/beta-catenin inhibition in the Niclosamide chemotype: identification of derivatives with improved drug exposure","volume":"23","author":"Mook","year":"2015","journal-title":"Bioorg. Med. Chem."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656817301018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656817301018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:13:14Z","timestamp":1692749594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656817301018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":108,"alternative-id":["S0898656817301018"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2017.04.001","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niclosamide: Beyond an antihelminthic drug","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}